Flagship Pioneering forges ahead with $618M capital raise
The capital raise is the culmination of a year that was punctuated with two of its portfolio companies filing initial public offerings and the hire of J.P. Morgan veteran Stephen Berenson.
The capital raise is the culmination of a year that was punctuated with two of its portfolio companies filing initial public offerings and the hire of J.P. Morgan veteran Stephen Berenson.
Quanterix and Banyan Biomarkers want to study two proteins about which not much is known but that show up in the blood when humans take a blow to their head.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Utilizing liquid biopsies and other forms of early detection are integral in Quanterix' technology designed to help detect disease before symptoms are even present.